Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Response to Letter to the Editor: "Aberrant Collagen Cross-linking in Human Oral Squamous Cell Carcinoma".

Uzawa K, Amelio AL, Tanzawa H, Yamauchi M.

J Dent Res. 2019 May 29:22034519853263. doi: 10.1177/0022034519853263. [Epub ahead of print] No abstract available.

PMID:
31140896
2.

A Bioluminescence Resonance Energy Transfer-Based Approach for Determining Antibody-Receptor Occupancy In Vivo.

Tang Y, Parag-Sharma K, Amelio AL, Cao Y.

iScience. 2019 May 31;15:439-451. doi: 10.1016/j.isci.2019.05.003. Epub 2019 May 8.

3.

Identification of NSDHL mutations associated with CHILD syndrome in oral verruciform xanthoma.

Getz GI, Parag-Sharma K, Reside J, Padilla RJ, Amelio AL.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2019 Feb 23. pii: S2212-4403(19)30148-8. doi: 10.1016/j.oooo.2019.02.015. [Epub ahead of print]

PMID:
31078502
4.

Aberrant Collagen Cross-linking in Human Oral Squamous Cell Carcinoma.

Saito T, Uzawa K, Terajima M, Shiiba M, Amelio AL, Tanzawa H, Yamauchi M.

J Dent Res. 2019 May;98(5):517-525. doi: 10.1177/0022034519828710. Epub 2019 Feb 20.

PMID:
30786814
5.

Adaptive Transcriptional Responses by CRTC Coactivators in Cancer.

Tasoulas J, Rodon L, Kaye FJ, Montminy M, Amelio AL.

Trends Cancer. 2019 Feb;5(2):111-127. doi: 10.1016/j.trecan.2018.12.002. Epub 2019 Jan 29. Review.

PMID:
30755304
6.

Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.

Fishbein L, Leshchiner I, Walter V, Danilova L, Robertson AG, Johnson AR, Lichtenberg TM, Murray BA, Ghayee HK, Else T, Ling S, Jefferys SR, de Cubas AA, Wenz B, Korpershoek E, Amelio AL, Makowski L, Rathmell WK, Gimenez-Roqueplo AP, Giordano TJ, Asa SL, Tischler AS; Cancer Genome Atlas Research Network, Pacak K, Nathanson KL, Wilkerson MD.

Cancer Cell. 2017 Feb 13;31(2):181-193. doi: 10.1016/j.ccell.2017.01.001. Epub 2017 Feb 2.

7.

cAMP/CREB-regulated LINC00473 marks LKB1-inactivated lung cancer and mediates tumor growth.

Chen Z, Li JL, Lin S, Cao C, Gimbrone NT, Yang R, Fu DA, Carper MB, Haura EB, Schabath MB, Lu J, Amelio AL, Cress WD, Kaye FJ, Wu L.

J Clin Invest. 2016 Jun 1;126(6):2267-79. doi: 10.1172/JCI85250. Epub 2016 May 3.

8.

Fluorophore-NanoLuc BRET Reporters Enable Sensitive In Vivo Optical Imaging and Flow Cytometry for Monitoring Tumorigenesis.

Schaub FX, Reza MS, Flaveny CA, Li W, Musicant AM, Hoxha S, Guo M, Cleveland JL, Amelio AL.

Cancer Res. 2015 Dec 1;75(23):5023-33. doi: 10.1158/0008-5472.CAN-14-3538. Epub 2015 Sep 30.

9.

LKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitment.

Peña CG, Nakada Y, Saatcioglu HD, Aloisio GM, Cuevas I, Zhang S, Miller DS, Lea JS, Wong KK, DeBerardinis RJ, Amelio AL, Brekken RA, Castrillon DH.

J Clin Invest. 2015 Nov 2;125(11):4063-76. doi: 10.1172/JCI82152. Epub 2015 Sep 28.

10.

Broad Anti-tumor Activity of a Small Molecule that Selectively Targets the Warburg Effect and Lipogenesis.

Flaveny CA, Griffett K, El-Gendy Bel-D, Kazantzis M, Sengupta M, Amelio AL, Chatterjee A, Walker J, Solt LA, Kamenecka TM, Burris TP.

Cancer Cell. 2015 Jul 13;28(1):42-56. doi: 10.1016/j.ccell.2015.05.007. Epub 2015 Jun 25.

11.

CREB targets define the gene expression signature of malignancies having reduced levels of the tumor suppressor tristetraprolin.

Fallahi M, Amelio AL, Cleveland JL, Rounbehler RJ.

PLoS One. 2014 Dec 26;9(12):e115517. doi: 10.1371/journal.pone.0115517. eCollection 2014.

12.

Role of LKB1-CRTC1 on glycosylated COX-2 and response to COX-2 inhibition in lung cancer.

Cao C, Gao R, Zhang M, Amelio AL, Fallahi M, Chen Z, Gu Y, Hu C, Welsh EA, Engel BE, Haura EB, Cress WD, Wu L, Zajac-Kaye M, Kaye FJ.

J Natl Cancer Inst. 2014 Dec 1;107(1):358. doi: 10.1093/jnci/dju358. Print 2015 Jan.

13.

CRTC1/MAML2 gain-of-function interactions with MYC create a gene signature predictive of cancers with CREB-MYC involvement.

Amelio AL, Fallahi M, Schaub FX, Zhang M, Lawani MB, Alperstein AS, Southern MR, Young BM, Wu L, Zajac-Kaye M, Kaye FJ, Cleveland JL, Conkright MD.

Proc Natl Acad Sci U S A. 2014 Aug 12;111(32):E3260-8. doi: 10.1073/pnas.1319176111. Epub 2014 Jul 28.

14.

Creb coactivators direct anabolic responses and enhance performance of skeletal muscle.

Bruno NE, Kelly KA, Hawkins R, Bramah-Lawani M, Amelio AL, Nwachukwu JC, Nettles KW, Conkright MD.

EMBO J. 2014 May 2;33(9):1027-43. doi: 10.1002/embj.201386145. Epub 2014 Mar 27.

15.

Blocking lactate export by inhibiting the Myc target MCT1 Disables glycolysis and glutathione synthesis.

Doherty JR, Yang C, Scott KE, Cameron MD, Fallahi M, Li W, Hall MA, Amelio AL, Mishra JK, Li F, Tortosa M, Genau HM, Rounbehler RJ, Lu Y, Dang CV, Kumar KG, Butler AA, Bannister TD, Hooper AT, Unsal-Kacmaz K, Roush WR, Cleveland JL.

Cancer Res. 2014 Feb 1;74(3):908-20. doi: 10.1158/0008-5472.CAN-13-2034. Epub 2013 Nov 27.

16.

Striatal microRNA controls cocaine intake through CREB signalling.

Hollander JA, Im HI, Amelio AL, Kocerha J, Bali P, Lu Q, Willoughby D, Wahlestedt C, Conkright MD, Kenny PJ.

Nature. 2010 Jul 8;466(7303):197-202. doi: 10.1038/nature09202.

17.

The transcriptional transactivator Tat selectively regulates viral splicing.

Jablonski JA, Amelio AL, Giacca M, Caputi M.

Nucleic Acids Res. 2010 Mar;38(4):1249-60. doi: 10.1093/nar/gkp1105. Epub 2009 Dec 4.

18.

Bipartite functions of the CREB co-activators selectively direct alternative splicing or transcriptional activation.

Amelio AL, Caputi M, Conkright MD.

EMBO J. 2009 Sep 16;28(18):2733-47. doi: 10.1038/emboj.2009.216. Epub 2009 Jul 30.

19.

A coactivator trap identifies NONO (p54nrb) as a component of the cAMP-signaling pathway.

Amelio AL, Miraglia LJ, Conkright JJ, Mercer BA, Batalov S, Cavett V, Orth AP, Busby J, Hogenesch JB, Conkright MD.

Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20314-9. Epub 2007 Dec 11.

Supplemental Content

Loading ...
Support Center